CVE-2023-38958
MEDIUMCVSS 5.3/10EPSS 0.32%
Last modified
CVE-2023-38958 is a medium-severity vulnerability rated 5.3/10 on the CVSS scale. An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request.. EPSS estimates a 0.32% chance of exploitation in the next 30 days.
Description
An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Zkteco | Bioaccess Ivs | 3.3.1 |
References
- http://zkteco.comProduct
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38958Third Party Advisory
- http://zkteco.comProduct
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38958Third Party Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-38958?
An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request.
How severe is CVE-2023-38958?
CVE-2023-38958 has a CVSS score of 5.3/10 (MEDIUM severity). The EPSS model estimates a 0.32% probability of exploitation in the next 30 days.
How do I fix CVE-2023-38958?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2023-38958?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST